Stroke, Vol 23, 1826-1839, Copyright © 1992 by American Heart Association
JM Wardlaw and CP Warlow
BACKGROUND: This article is presented to provoke further discussion
regarding the use of thrombolytic drugs to treat acute ischemic stroke.
SUMMARY OF REVIEW: Overview analysis of the six randomized trials of
thrombolysis in acute ischemic stroke available in the world literature
shows a 20% increase in the odds of death and a 30% reduction in the odds
of death or deterioration (both with wide confidence intervals, neither
result significant) after thrombolytic treatment for acute ischemic stroke.
Exclusion of the two trials conducted without the benefit of computed
tomographic scanning shows a 37% reduction in the odds of death (95%
confidence interval, 74% reduction to 40% excess) and a significant
reduction of 56% in the odds of death or deterioration after thrombolytic
treatment (95% confidence interval, 20- 76% reduction; 2p = 0.007).
Analysis of all published studies (randomized and nonrandomized) shows that
there does not appear to be an excess risk of hemorrhagic transformation of
the cerebral infarct or of severe edema formation. CONCLUSIONS: We believe
the present evidence is sufficiently encouraging to warrant proper testing
of thrombolysis in sufficiently large and well-designed randomized clinical
trials to influence clinical practice.
ARTICLES
Thrombolysis in acute ischemic stroke: does it work?
Department of Clinical Neurosciences, Western General Hospital, Edinburgh, UK.
This article has been cited by other articles:
![]() |
R.M. Sugg, E.A. Noser, H.M. Shaltoni, N.R. Gonzales, M.S. Campbell, R. Weir, E.D. Cacayorin, and J.C. Grotta Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke. AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 769 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.R. Lees, D. Barer, G.A. Ford, W. Hacke, V. Kostulas, A.K. Sharma, and T. Odergren Tolerability of NXY-059 at Higher Target Concentrations in Patients With Acute Stroke Stroke, February 1, 2003; 34(2): 482 - 487. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakano, T. Iseda, T. Yoneyama, H. Kawano, and S. Wakisaka Direct Percutaneous Transluminal Angioplasty for Acute Middle Cerebral Artery Trunk Occlusion: An Alternative Option to Intra-arterial Thrombolysis Stroke, December 1, 2002; 33(12): 2872 - 2876. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. F. Baker Jr Thrombolytic Therapy Clinical and Applied Thrombosis/Hemostasis, October 1, 2002; 8(4): 291 - 314. [PDF] |
||||
![]() |
T. Yoneyama, S. Nakano, H. Kawano, T. Iseda, T. Ikeda, T. Goya, and S. Wakisaka Combined Direct Percutaneous Transluminal Angioplasty and Low-Dose Native Tissue Plasminogen Activator Therapy for Acute Embolic Middle Cerebral Artery Trunk Occlusion AJNR Am. J. Neuroradiol., February 1, 2002; 23(2): 277 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Wardlaw Overview of Cochrane thrombolysis meta-analysis Neurology, September 1, 2001; 57(90002): S69 - 76. [Abstract] [Full Text] |
||||
![]() |
G. W. Albers Advances in intravenous thrombolytic therapy for treatment of acute stroke Neurology, September 1, 2001; 57(90002): S77 - 81. [Abstract] [Full Text] |
||||
![]() |
G. W. Albers, P. Amarenco, J. D. Easton, R. L. Sacco, and P. Teal Antithrombotic and Thrombolytic Therapy for Ischemic Stroke Chest, January 1, 2001; 119(1_suppl): 300S - 320S. [Full Text] [PDF] |
||||
![]() |
J. A. Hinchey and C. Benesch Thrombolytic Therapy in Patients With Acute Ischemic Stroke Arch Neurol, October 1, 2000; 57(10): 1430 - 1436. [Full Text] [PDF] |
||||
![]() |
K. H. Lee, S. J. Lee, S.-J. Cho, D. G. Na, H. S. Byun, Y.-B. Kim, H.-J. Song, I.-S. Jin, and C.-S. Chung Usefulness of Triphasic Perfusion Computed Tomography for Intravenous Thrombolysis With Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Arch Neurol, July 1, 2000; 57(7): 1000 - 1008. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. W. Albers Expanding the Window for Thrombolytic Therapy in Acute Stroke : The Potential Role of Acute MRI for Patient Selection Stroke, October 1, 1999; 30(10): 2230 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Davis and D. Barer Neuroprotection in acute ischaemic stroke. II: Clinical potential Vascular Medicine, August 1, 1999; 4(3): 149 - 163. [Abstract] [PDF] |
||||
![]() |
R. Jahan, G. R. Duckwiler, C. S. Kidwell, J. W. Sayre, Y. P. Gobin, J. PabloVillablanca, J. Saver, S. Starkman, N. Martin, and F. Vinuela Intraarterial Thrombolysis for Treatment ofAcute Stroke: Experience in 26 Patients withLong-Term Follow-up AJNR Am. J. Neuroradiol., August 1, 1999; 20(7): 1291 - 1299. [Abstract] [Full Text] |
||||
![]() |
N. J. Beauchamp Jr, P. B. Barker, P. Y. Wang, and P. C. M. vanZijl Imaging of Acute Cerebral Ischemia Radiology, August 1, 1999; 212(2): 307 - 324. [Abstract] [Full Text] |
||||
![]() |
T. F. Choudhri, B. L. Hoh, R. A. Solomon, E. S. Connolly Jr, and D. J. Pinsky Use of a Spectrophotometric Hemoglobin Assay to Objectively Quantify Intracerebral Hemorrhage in Mice Stroke, November 1, 1997; 28(11): 2296 - 2302. [Abstract] [Full Text] |
||||
![]() |
H. P. Adams, T. G. Brott, A. J. Furlan, C. R. Gomez, J. Grotta, C. M. Helgason, T. Kwiatkowski, P. D. Lyden, J. R. Marler, J. Torner, et al. Guidelines for Thrombolytic Therapy for Acute Stroke: A Supplement to the Guidelines for the Management of Patients With Acute Ischemic Stroke: A Statement for Healthcare Professionals From a Special Writing Group of the Stroke Council, American Heart Association Circulation, September 1, 1996; 94(5): 1167 - 1174. [Full Text] |
||||
![]() |
The Multicenter Acute Stroke Trial -- Europe Study Thrombolytic Therapy with Streptokinase in Acute Ischemic Stroke N. Engl. J. Med., July 18, 1996; 335(3): 145 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. von Kummer, R. Holle, L. Rosin, M. Forsting, and W. Hacke Does Arterial Recanalization Improve Outcome in Carotid Territory Stroke? Stroke, April 1, 1995; 26(4): 581 - 587. [Abstract] [Full Text] |
||||
![]() |
Z. Nagy, K. Kolev, E. Csonka, M. Pek, and R. Machovich Contraction of Human Brain Endothelial Cells Induced by Thrombogenic and Fibrinolytic Factors : An In Vitro Cell Culture Model Stroke, February 1, 1995; 26(2): 265 - 270. [Abstract] [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |